Second Alzheimer's drug in pipeline can slow the disease by a few months but with safety risk
WASHINGTON (AP) - Another experimental Alzheimer's drug can modestly slow patients' inevitable worsening - by about four to seven months, researchers reported Monday. Eli Lilly and…
